The LnCaP is a hormone sensitive cell line, which was developed from a prostate cancer metastasis to a lymph node, expresses a number of restricted differentiation antigens, including prostate-specific antigen (PSA), prostate-specific membrane antigen and a mutant androgen receptor [34]. The gene discussed is KLK3; the disease is prostate carcinoma.